Home Biosimilar Antibodies Immunology & Inflammation PD-1/PD-L1 antibody Balstilimab (Anti-PDCD1 / PD-1 / CD279) For research use only.
Not for use in humans.

Balstilimab (Anti-PDCD1 / PD-1 / CD279)

Synonyms: AGEN 2034

Balstilimab (Anti-PDCD1 / PD-1 / CD279) is a monoclonal antibody targeting the programmed cell death 1 (PD-1, PCD-1; PDCD1). It exhibits potential treatment of cervical cancer. MW :137.3 KD.

Balstilimab (Anti-PDCD1 / PD-1 / CD279)

Purity & Quality Control

≥99

Choose Selective PD-1/PD-L1 Inhibitors

Biological Activity

Description Balstilimab (Anti-PDCD1 / PD-1 / CD279) is a monoclonal antibody targeting the programmed cell death 1 (PD-1, PCD-1; PDCD1). It exhibits potential treatment of cervical cancer. MW :137.3 KD.

Product Details

CAS No. 2230167-06-1
Isotype Human IgG4SP
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Balstilimab (Anti-PDCD1 / PD-1 / CD279) | Balstilimab (Anti-PDCD1 / PD-1 / CD279) supplier | purchase Balstilimab (Anti-PDCD1 / PD-1 / CD279) | Balstilimab (Anti-PDCD1 / PD-1 / CD279) cost | Balstilimab (Anti-PDCD1 / PD-1 / CD279) manufacturer | order Balstilimab (Anti-PDCD1 / PD-1 / CD279) | Balstilimab (Anti-PDCD1 / PD-1 / CD279) distributor